About Ethris
Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. We are using our proprietary technologies to develop a new approach for the treatment of pulmonary diseases, especially those with high unmet need such as Primary Ciliary Dyskinesia (PCD).
Our Technology
Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technologies. Our integrated platform enables the discovery, design and development of transcript therapies to address an array of diverse and challenging disease indications.
About Ethris
Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. We are using our proprietary technologies to develop a new approach for the treatment of pulmonary diseases.
Our Technology
Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technologies. Our integrated platform enables the discovery, design and development of transcript therapies.
